laboratory abnormalities, comorbid conditions, and prescribed medications. Independent of these associations, systolic intervisit variability was found to predict all-cause mortality, thus reinforcing and expanding on previous reports by Rothwell et al. 2 Muntner et al, 1 as well as previous investigators, found a relation between intervisit BP variability and prescribed medications. They report that medications were more frequently used in patients in the upper tertile of systolic BP variability. However, the causality, mechanisms and class-specific characteristics of this relationship have not been established. We suggest that heart rate may bear on BP variability and may also partially mediate the relationship between medications and intervisit variability. Both precision and accuracy of BP measurement (assuming constant cuff deflation rate) are compromised in the face of lower heart rate. 3,4 Thus, bradycardia, whether related or not to the use of medications, might be a confounder contributing to apparently increased intervisit BP variability and possibly affecting outcome differences.
